Cannabis Law Report
AUGUST 24, 2021
Nasdaq:HUGE) (CSE:HUGE) (FRA:0K9) (the “ Company ” or “ FSD ”) announced today that it intends to terminate the Phase 2 clinical trial of ultra-micronized palmitoylethanolamide (“PEA”), or FSD-201, for use in treating COVID-19. TORONTO–(BUSINESS WIRE)–FSD Pharma Inc.
The Cannigma
OCTOBER 11, 2021
When asked what concentration of CBG appears to be most effective, Dr. Ethan Russo, one of the authors of the study, told The Cannigma “I would not put it in terms of concentration. No clinical trial was used in the compilation of the study. Rather, doses of CBG of 5 mg or above orally seem to exert noticeable effects.”.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
SpeedWeed
FEBRUARY 18, 2021
“From a clinical perspective, we found that treatment with cannabis led to a significant reduction in the Lichtiger Disease Activity Index and improvement in major IBD-related clinical symptoms including abdominal pain and number of bowel movements per day,” the results from the study claimed regarding the findings. “We
Project CBD
MARCH 21, 2023
Whatever the precise nature of the phantom sound, it often comes with a constellation of symptoms related to the disruption such a condition can bring: sleep problems, difficulty concentrating, low mood, etc. Estimates vary, but tens of millions of people in the United States alone likely suffer from chronic tinnitus.
Veriheal
JANUARY 11, 2023
Not only this, but Gaize recently completed the largest clinical trial into cannabis impairment , and the results are set to transform the realm of workplace and road safety. Studies on cannabis have shown that the plant may cause disorientation, sedation, lack of concentration, and impaired judgment. Here’s what he had to say.
NORML
JANUARY 4, 2019
Separate provisions in the bill exclude cannabidiol from the federal definition of marijuana, permit VA doctors to authorize medical cannabis access to qualified patients, and remove undue federal barriers to clinical trial research to better assess the safety and efficacy of medical cannabis. NH resident?
The Cannigma
MAY 6, 2021
Delta-9-THC and CBD can be found in concentrations as high as 20% and even 30%, but minor cannabinoids such as delta-8-THC generally occur in concentrations below 1%. had no measurable concentrations of delta-8-THC. Of the ones that did contain delta-8, the average concentration was only about 0.0018%”. Shutterstock).
Expert insights. Personalized for you.
81 
Let's personalize your content